prostate header graphic
Prostate Problem Guide

Assessing The Symptoms Of Benign Prostatic Hypertrophy

One of the problems with benign prostatic hypertrophy (an enlargement of the prostate which affects the majority of men above the age of 60) is that the symptoms can vary widely from one person to the next and it can be difficult to assess the degree of treatment required, or indeed whether treatment is needed at all.

To assist in this assessment the American Urological Association has designed a short questionnaire consisting of just seven questions.

For the first six questions you allocate yourself a score according to your answers as follows:

0 points - not at all.
1 point - less than 1 time in 5.
2 points - less than half the time.
3 points - about half the time.
4 points - more than half the time.
5 points - almost always.

The questions, which apply to the previous period of one month, are:

1. How often have you experienced a sensation of not emptying your bladder after urinating?
2. How often have you had to urinate less than two hours after your previous urination?
3. How often have you stopped and started again several times during urination?
4. How often have you experienced an urgent need to urinate and found it difficult to hold on?
5. How often have you experienced a weak flow of urine?
6. How often have you felt the need to urinate but have had to strain to begin urination?

For the seventh question, which also applies to the previous month, you simply allocate a point score equal to your answer (up to a maximum of 5). So, if your answer is twice you allocate 2 points and if your answer is four times you give yourself 4 points. The question is:

7. On average, how many times have you had to get up during the night to urinate?

Once you have completed the questionnaire and allocated a points score to each answer you then total up your score, which will fall somewhere between 0 and 35. The higher your score the more severe your symptoms and the greater your need for treatment. In general, a score of 7 or less would indicate that your condition does not warrant treatment at this time.

It should be stressed that this test is just one test among several that your doctor may use to assess whether you are suffering from benign prostatic hypertrophy and, if so, what treatment would be appropriate. It is not designed to be used in isolation or for self-diagnosis.

If you are experiencing problems and suspect that you may be suffering from benign prostatic hypertrophy then you should consult your doctor.

Further information on benign prostatic hypertrophy:

Fine Treatment Highlights the Need for Men to Reconsider Prostate Treatment ... - San Francisco Chronicle (press release)


PR Web

Fine Treatment Highlights the Need for Men to Reconsider Prostate Treatment ...
San Francisco Chronicle (press release)
Men suffering from benign prostatic hyperplasia (BPH) should consider alternative treatments to prostate surgery for the relief of symptoms and ought to consider new Thermobalancing Therapy in the first place as it is safe and effective, Fine Treatment ...
Prevent Complications from BPH Drugs and Antibiotics with New Thermobalancing ...Seattle Post Intelligencer
Long Term Treatment of Symptomatic BPH with Potentially Harmful Drugs Should ...Virtual-Strategy Magazine

all 24 news articles »

Urologix Announces Three Events at the 107th Annual Meeting of the American ... - NASDAQ


Urologix Announces Three Events at the 107th Annual Meeting of the American ...
NASDAQ
Sponsor of Expert Panel Lecture on In-Office BPH Therapies, Moderated by Dr. Claus Roehrborn Presentation of Cooled ThermoTherapy™ (CTT) Clinical Outcomes for Improving Nocturia by Dr. Lori Lerner MINNEAPOLIS, May 14, 2012 (GLOBE NEWSWIRE) -- Urologix ...

and more »

Prostate Protection from Enlargement Can Be Achieved Naturally with New ... - San Francisco Chronicle (press release)


Prostate Protection from Enlargement Can Be Achieved Naturally with New ...
San Francisco Chronicle (press release)
The prevention of prostate enlargement is one of key factors of men's well-being. London, UK (PRWEB) May 12, 2012 New Thermobalancing Therapy can terminate benign prostatic hyperplasia (BPH) or slowly progressive enlargement of the prostate, ...

and more »

Nymox NX-1207 Symposium at American Urological Association Annual Meeting May ... - MarketWatch (press release)


Nymox NX-1207 Symposium at American Urological Association Annual Meeting May ...
MarketWatch (press release)
HASBROUCK HEIGHTS, NJ, May 16, 2012 (GlobeNewswire via COMTEX) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce a symposium and panel discussion on NX-1207, the Company's Phase 3 drug for benign prostatic hyperplasia (BPH), ...
NYMOX PHARMACEUTICAL CORPORATION : Nymox NX-1207 Symposium at American ...4-traders

all 4 news articles »